SU

238.1

+1.28%↑

BAS

52.36

+3.03%↑

REP

24.12

-0.41%↓

AM

335.2

+0.12%↑

EXE.US

103.5

-0.29%↓

SU

238.1

+1.28%↑

BAS

52.36

+3.03%↑

REP

24.12

-0.41%↓

AM

335.2

+0.12%↑

EXE.US

103.5

-0.29%↓

SU

238.1

+1.28%↑

BAS

52.36

+3.03%↑

REP

24.12

-0.41%↓

AM

335.2

+0.12%↑

EXE.US

103.5

-0.29%↓

SU

238.1

+1.28%↑

BAS

52.36

+3.03%↑

REP

24.12

-0.41%↓

AM

335.2

+0.12%↑

EXE.US

103.5

-0.29%↓

SU

238.1

+1.28%↑

BAS

52.36

+3.03%↑

REP

24.12

-0.41%↓

AM

335.2

+0.12%↑

EXE.US

103.5

-0.29%↓

Search

H&R GmbH & Co KGaA

Avatud

3.94

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.93

Max

3.94

Põhinäitajad

By Trading Economics

Sissetulek

970K

-662K

Müük

3.3M

311M

Dividenditootlus

2.01

Kasumimarginaal

-0.213

Soovitused

By TipRanks

Soovitused

Müü

12 kuu keskmine prognoos

-11.11% downside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.01%

3.17%

Järgmine tulemuste avaldamine

15. mai 2026

Turustatistika

By TradingEconomics

Turukapital

260M

Eelmine avamishind

3.94

Eelmine sulgemishind

3.94

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

H&R GmbH & Co KGaA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk
Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk
Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

H&R GmbH & Co KGaA Prognoos

Hinnasiht

By TipRanks

-11.11% langus

12 kuu keskmine prognoos

Keskmine 3.6 EUR  -11.11%

Kõrge 3.6 EUR

Madal 3.6 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi H&R GmbH & Co KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

1 ratings

0

Osta

0

Hoia

1

Müü

Tehniline skoor

By Trading Central

3.94 / 4Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Finantsandmed

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

Ärikasum

$

Ettevõttest H&R GmbH & Co KGaA

H&R GmbH & Co. KGaA
help-icon Live chat